Phase II study of a new combined primary chemotherapy regimen, intravenous methotrexate and vincristine and intraarterial Adriamycin and cisplatin, for locally advanced urinary bladder cancer: preliminary results

1995 ◽  
Vol 35 (5) ◽  
pp. 357-363 ◽  
Author(s):  
Toshiro Kuroiwa ◽  
Seiji Naito ◽  
Kanehiro Hasuo ◽  
Takashi Kishikawa ◽  
Kouji Masuda ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Urinary Bladder ◽  
Phase Ii ◽  
Chemotherapy Regimen ◽  
Phase Ii Study ◽  
Locally Advanced ◽  
Urinary Bladder Cancer ◽  
Primary Chemotherapy ◽  
Preliminary Results

scholarly journals OC-0547: Acute and late morbidity in a Phase II trial of adaptive radiotherapy for urinary bladder cancer

2017 ◽  
Vol 123 ◽  
pp. S291-S292
Author(s):  
A. Vestergaard ◽  
L. Muren ◽  
H. Lindberg ◽  
L. Dysager ◽  
K. Jakobsen ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Urinary Bladder ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Urinary Bladder Cancer ◽  
Adaptive Radiotherapy ◽  
Late Morbidity

scholarly journals OC-0107: Normal tissue sparing in a Phase II trial of daily adaptive plan selection in radiotherapy for urinary bladder cancer

2015 ◽  
Vol 115 ◽  
pp. S51-S52
Author(s):  
A. Vestergaard ◽  
L.P. Muren ◽  
H. Lindberg ◽  
K.L. Jakobsen ◽  
J.B.B. Petersen ◽  
...  
Keyword(s):  
Bladder Cancer ◽  
Urinary Bladder ◽  
Phase Ii ◽  
Normal Tissue ◽  
Phase Ii Trial ◽  
Urinary Bladder Cancer ◽  
Normal Tissue Sparing ◽  
Plan Selection ◽  
Tissue Sparing
Sign in / Sign up

Export Citation Format

Share Document